ETX.L Regulatory News (ETX)

5 Feb 2008 12:02

e-Therapeutics plc05 February 2008 e-Therapeutics plc (the "Company") Notification of Change of Interest in the Company's Share Capital On 4 February 2008, the Company received notification that, following disposalsof a total of 200,000 ordinary shares of 0.1p each in the capital of the Company("Ordinary Shares") between 28 January 2008 and 31 January 2008 (the individualdisposals were: 100,000 Ordinary Shares on 28 January, 25,000 Ordinary Shares onboth 29 and 30 January and 50,000 Ordinary Shares on 31 January), RAB SpecialSituations (Master) Fund Limited ("RAB") is the beneficial owner of 17,207,950Ordinary Shares, representing 30.89 per cent. of the total number of OrdinaryShares and of the total voting rights of the Company. The registered holder ofthese Ordinary Shares is Credit Suisse Client Nominees (UK) Limited. RAB has only disposed of a very small proportion of its Ordinary Shares andremains a strong supporter of the Company going forward. For more information please contact:John Cordiner, e-Therapeutics plc Tel: 0191 233 1317 Richard Lindley, WH Ireland Limited Tel: 0113 394 6628 This information is provided by RNS The company news service from the London Stock Exchange